Simultaneous occurrence of obstructive jaundice and proteinlosing enteropathy in Hodgkin’s lymphoma

Main Article Content

Mohammad Reza Bordbar
Pediatric Hematology-Oncology assistant profossor Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Babak Abdolkarimi
Hematology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran;

Mandana Tasbihi
Pediatric Hematology-Oncology fellowship Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Bita Geramizadeh
profossor of Pathology Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran

Amir Reza Dehghanian
Pathology assistant profossor Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran

Soheila Zareifar
Pediatric Hematology-Oncology associated profossor Hematology Research Center. Shiraz University of Medical Sciences Shiraz, Iran

Mehran Karimi
Pediatric Hematology-Oncology assistant profossor Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Keywords

Hodgkin lymphoma, ascites, obstructive jaundice, protein losing enteropathy

Abstract

Protein-losing enteropathy (PLE) and obstructive jaundice as initial findings of Hodgkin’s lymphoma are extremely rare in childhood. The diagnosis of PLE and obstructive cholestasis is critical because early diagnosis and treatment are important for improving survival in patients with Hodgkin’s lymphoma.
Abstract 67 | PDF Downloads 46

Article Sidebar

PDF
Published
Feb 10, 2015

Article Details

How to Cite

1.
Simultaneous occurrence of obstructive jaundice and proteinlosing enteropathy in Hodgkin’s lymphoma. Eur J Oncol [Internet]. 2015 Feb. 10 [cited 2024 Jul. 18];19(2):112-3. Available from: https://mattioli1885journals.com/index.php/EJOEH/article/view/3335
Issue
European Journal of Oncology Vol.19, No 2 (2014)
Section
Letters to the Editor

OPEN ACCESS

All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.

The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).

Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.

How to Cite

1.
Simultaneous occurrence of obstructive jaundice and proteinlosing enteropathy in Hodgkin’s lymphoma. Eur J Oncol [Internet]. 2015 Feb. 10 [cited 2024 Jul. 18];19(2):112-3. Available from: https://mattioli1885journals.com/index.php/EJOEH/article/view/3335